🇺🇸 FDA
Pipeline program

Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)

060401

Phase 3 small_molecule completed

Quick answer

Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM) for Hemophilia A is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hemophilia A
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials